{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:21:03Z","timestamp":1785403263728,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300894"],"award-info":[{"award-number":["81300894"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013318","name":"ShanXi Science and Technology Department","doi-asserted-by":"publisher","award":["201901D1112020"],"award-info":[{"award-number":["201901D1112020"]}],"id":[{"id":"10.13039\/501100013318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jiac.2021.09.018","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T02:11:07Z","timestamp":1634695867000},"page":"29-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Activity of chlorhexidine acetate in combination with fluconazole against suspensions and biofilms of Candida auris"],"prefix":"10.1016","volume":"28","author":[{"given":"Weifeng","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.09.018_bib1","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997-2016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2021.09.018_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital","volume":"53","author":"Satoh","year":"2009","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jiac.2021.09.018_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40560-018-0342-4","article-title":"Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris","volume":"6","author":"Cortegiani","year":"2018","journal-title":"J Intensive Care"},{"key":"10.1016\/j.jiac.2021.09.018_bib4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1017\/ice.2017.127","article-title":"Environmental surfaces in healthcare facilities are a potential source for transmission of Candida auris and other Candida species","volume":"38","author":"Piedrahita","year":"2017","journal-title":"Infect Contr Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2021.09.018_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02396-16","article-title":"The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation","volume":"61","author":"Larkin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2021.09.018_bib6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/14787210.2017.1364992","article-title":"Candida auris: a worrisome, globally emerging pathogen","volume":"15","author":"Navalkele","year":"2017","journal-title":"Expert Rev Anti-infect Ther"},{"key":"10.1016\/j.jiac.2021.09.018_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.09.018_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2019.20288","article-title":"FDA approval and regulation of pharmaceuticals, 1983-2018","volume":"323","author":"Darrow","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.jiac.2021.09.018_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11908-007-0069-1","article-title":"Combination antifungal therapy for the treatment of invasive yeast and mold infections","volume":"9","author":"Baddley","year":"2007","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jiac.2021.09.018_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8050749","article-title":"Novel Bi-factorial strategy against Candida albicans viability using carnosic acid and propolis: synergistic antifungal action","volume":"8","author":"Arg\u00fcelles","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.jiac.2021.09.018_bib11","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3389\/fmicb.2018.02892","article-title":"Strong synergism of palmatine and fluconazole\/itraconazole against planktonic and biofilm cells of Candida species and efflux-associated antifungal mechanism","volume":"9","author":"Wang","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2021.09.018_bib12","first-page":"1321","article-title":"Chlorhexidine--pharmaco-biological activity and application","volume":"19","author":"Karpi\u0144ski","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jiac.2021.09.018_bib13","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"key":"10.1016\/j.jiac.2021.09.018_bib14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jiac.2020.12.012","article-title":"Identification of disulfiram as a potential antifungal drug by screening small molecular libraries","volume":"27","author":"Hao","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.09.018_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.archoralbio.2018.02.009","article-title":"Stability and efficacy of combined nystatin and chlorhexidine against suspensions and biofilms of Candida albicans","volume":"89","author":"Scheibler","year":"2018","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.jiac.2021.09.018_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2021.09.018_bib17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11046-017-0135-7","article-title":"The effectiveness of voriconazole in therapy of Candida glabrata's biofilms oral infections and its influence on the matrix composition and gene expression","volume":"182","author":"Rodrigues","year":"2017","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jiac.2021.09.018_bib18","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/nprot.2008.192","article-title":"In vitro growth and analysis of Candida biofilms","volume":"3","author":"Chandra","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jiac.2021.09.018_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061307","article-title":"Candida albicans impairments induced by peppermint and clove oils at sub-inhibitory concentrations","volume":"18","author":"Rajkowska","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiac.2021.09.018_bib20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41598-020-58203-3","article-title":"Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris","volume":"10","author":"Shaban","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2021.09.018_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.578","article-title":"Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen","volume":"7","author":"Osei Sekyere","year":"2018","journal-title":"Microbiologyopen"},{"key":"10.1016\/j.jiac.2021.09.018_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00458-19","article-title":"Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris","volume":"4","author":"Kean","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.jiac.2021.09.018_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10123-018-00043-3","article-title":"Combination therapy of clinically approved antifungal drugs is enhanced by conjugation with silver nanoparticles","volume":"22","author":"Hussain","year":"2019","journal-title":"Int Microbiol"},{"key":"10.1016\/j.jiac.2021.09.018_bib24","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ijantimicag.2018.08.016","article-title":"Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris","volume":"52","author":"Eldesouky","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2021.09.018_bib25","first-page":"255","article-title":"Susceptibility of various microorganisms to chlorhexidine","volume":"85","author":"Emilson","year":"1977","journal-title":"Scand J Dent Res"},{"key":"10.1016\/j.jiac.2021.09.018_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12903-017-0400-7","article-title":"Comparing the effect of 0.06% -, 0.12% and 0.2% Chlorhexidine on plaque, bleeding and side effects in an experimental gingivitis model: a parallel group, double masked randomized clinical trial","volume":"17","author":"Haydari","year":"2017","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.jiac.2021.09.018_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0887-2333(01)00020-0","article-title":"Mechanisms underlying chlorhexidine-induced cytotoxicity","volume":"15","author":"Hidalgo","year":"2001","journal-title":"Toxicol Vitro : an international journal published in association with BIBRA"},{"key":"10.1016\/j.jiac.2021.09.018_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00189-16","article-title":"Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species","volume":"1","author":"Borman","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.jiac.2021.09.018_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3201\/eid2302.161320","article-title":"Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris","volume":"23","author":"Sherry","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2021.09.018_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/676533","article-title":"Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update","volume":"35","author":"Marschall","year":"2014","journal-title":"Infect Contr Hosp Epidemiol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21002671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21002671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:04:00Z","timestamp":1761159840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21002671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1341321X21002671"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.09.018","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of chlorhexidine acetate in combination with fluconazole against suspensions and biofilms of Candida auris","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}